| dc.contributor.author | Grimes, Tamasine | en |
| dc.date.accessioned | 2021-08-26T08:11:11Z | |
| dc.date.available | 2021-08-26T08:11:11Z | |
| dc.date.issued | 2022 | en |
| dc.date.submitted | 2022 | en |
| dc.identifier.citation | Grimes, Tamasine C, Is it time for greater patient involvement to enhance transitional medication safety?, BMJ Quality & Safety, 31, 2022, 247-250 | en |
| dc.identifier.issn | 2044-5415 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.format.extent | 247-250 | en |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | BMJ Quality & Safety | en |
| dc.relation.ispartofseries | 31 | en |
| dc.rights | Y | en |
| dc.subject | MARQUIS2 | en |
| dc.subject | Patient involvement | en |
| dc.subject | Medication | en |
| dc.title | Is it time for greater patient involvement to enhance transitional medication safety? | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/tagrimes | en |
| dc.identifier.rssinternalid | 232799 | en |
| dc.identifier.doi | http://dx.doi.org/10.1136/bmjqs-2021-014116 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.rssuri | https://qualitysafety.bmj.com/content/early/2021/08/19/bmjqs-2021-014116 | en |
| dc.identifier.orcid_id | 0000-0002-7154-3243 | en |
| dc.identifier.uri | https://qualitysafety.bmj.com/content/early/2021/08/19/bmjqs-2021-014116 | |
| dc.identifier.uri | http://hdl.handle.net/2262/96966 | |
